Novel Approaches for Oral Insulin Delivery - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Novel Approaches for Oral Insulin Delivery
The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin.


Pharmaceutical Technology
Volume 33, Issue 7

33. N. Zhang et al., "Investigation of Lectin-Modified Insulin Liposomes as Carriers for Oral Administration," Int. J. Pharm. 294 (1–2), 247–59 (2005).

34. M. Ramadas et al., "Lipoinsulin Encapsulated Alginate-Chitosan Capsules: Intestinal Delivery in Diabetic Rats," J. Microencapsul. 17 (4), 405–411 (2000).

35. D. Attivi et al., "Formulation of Insulin-Loaded Polymeric Nanoparticles using Response Surface Methodology," Drug Dev. Ind. Pharm. 31 (2), 179–189 (2005).

36. D.R. Bhumkar et al., "Chitosan-Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin," Pharm. Res. 23 (2007).

37. C. Damge et al., "Poly (alkyl cyanoacrylate) Nanospheres for Oral Adminiatration of Insulin," J Pharm Sci. 86 1403–1409 (1997).

38. C. Damge, P. Maincent, and N. Ubrich, "Oral Delivery of Insulin Associated to Polymeric Nanoparticles in Diabetic Rats," J Control Release 117 (2), 163–170, Epub 2006 (2007).

39. K.B. Chalasani et al., "A Novel Vitamin B12-Nanosphere Conjugate Carrier System for Peroral Delivery of Insulin," J Control Release 117 (3), 421–429 Epub 2006, (2007).

40. Y.H. Lin et al., "Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery," Biomacromolecules 8 (1), 146–152. (2007).

41. F.D. Cui et al., "Preparation of Insulin-Loaded PLGA-Hp55 Nanoparticles for Oral Delivery," J. Pharm Sci. 96 (2), 421–427. (2007).

42. B. Sarmento et al., "Development and Characterization of New Insulin Containing Polysaccharide Nanoparticles," Colloids Surf B. Biointerfaces 53 (2), 193–202, (2006).

43. W. Tiyaboonchai et al., "Insulin Containing Polyethylenimine-Dextran Sulfate Nanoparticles," Int. J. Pharm. 255 (1–2), 139–51 (2006).

44. M. Simon et al., "Nanosized Insulin-Complexes based on BioDegradable Amine-Modified Graft Polyesters Poly(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): Protection Against Enzymatic Degradation, Interaction with Caco-2 Cell Monolayers, Peptide Transport and Cytotoxicity," Eur. J. Pharm. Biopharm. 66 (2), 165–172 (2007).

45. H. Tozaki et al., "Enhanced Absorption of Insulin and (Asu(1,7))eel-calcitonin Using Novel Azopolymer-Coated Pellets for Colon-Specific Drug Delivery," J. Pharm. Sci. 90 (1), 89–97 (2001).

46. H. Ichikawa and Y. Fukumori, "Design of Nanohydrogel-Incorporated Microcapsules for Appropriate Controlled-Release of Peptide Drugs," Yakugaku Zasshi 127 (5), 813–823 (2007).

47. K. Whitehead, Z. Shen, and S. Mitragotri, "Oral Delivery of Macromolecules Using Intestinal Patches: Applications for Insulin Delivery," J. Control. Release 98 (1), 37–45 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here